Experts are increasingly examining retatrutide, a novel drug created by Eli Lilly, as a significant advance in physique management. Different than many existing approaches, retatrutide is a dual -action compound targeting simultaneously GLP-1 and GIP, chemicals that affect hunger and glucose reg… Read More